KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Current Assets (2016 - 2025)

Pfizer (PFE) has disclosed Current Assets for 17 consecutive years, with $42.9 billion as the latest value for Q4 2025.

  • On a quarterly basis, Current Assets fell 14.81% to $42.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $42.9 billion, a 14.81% decrease, with the full-year FY2025 number at $42.9 billion, down 14.81% from a year prior.
  • Current Assets was $42.9 billion for Q4 2025 at Pfizer, down from $46.9 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $177.9 billion in Q4 2021 to a low of $5.9 billion in Q4 2022.
  • A 5-year average of $50.0 billion and a median of $43.7 billion in 2025 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: soared 407.35% in 2021, then tumbled 71.19% in 2022.
  • Pfizer's Current Assets stood at $177.9 billion in 2021, then crashed by 71.19% to $51.3 billion in 2022, then dropped by 15.46% to $43.3 billion in 2023, then increased by 16.21% to $50.4 billion in 2024, then fell by 14.81% to $42.9 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Current Assets are $42.9 billion (Q4 2025), $46.9 billion (Q3 2025), and $43.7 billion (Q2 2025).